Lung Cancer
Lung cancer is a type of cancer that begins in the lungs, often leading to symptoms like persistent cough, chest pain, and difficulty breathing. It can be caused by factors such as smoking and exposure to certain toxins.
Sacituzumab Govitecan with Bevacizumab for Brain Metastases in Lung Cancer
We are studying a combination of two medications for patients with brain metastases from non-small cell lung cancer. The goal is to see how well this treatment works in reducing tumor size and improving patient outcomes.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you at least 18 years old?
- Do you have metastatic non-squamous lung cancer?
- Are you currently pregnant or breastfeeding?
- Are you taking blood thinners like Warfarin, Eliquis, or Xarelto?
- Have you had any major surgery in the past 3 months?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Vegzelma
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Netherlands Cancer Institute
Pulmonary Diseases
Amstelveen, Netherlands
Universitair Medisch Centrum Groningen
Pulmonary disease
Groningen, Netherlands
Academisch Ziekenhuis Maastricht
Department of Pulmonary Diseases
Maastricht, Netherlands
Sponsor: Academisch Ziekenhuis Maastricht
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.